BOSTON -- It was a strange weekend at the annual meeting of the American Association for the Study of Liver Disease. There wasn’t much clinical data presented, at least data of interest to investors. Instead, all of the Wall Street action was taking place in a few hotel conference rooms within walking distance of the convention center.
